Alpha 2.0
Login Register
» Articles » PMID: 16848669

Memantine for Disruptive Behavior in Autistic Disorder

Overview
Journal J Clin Psychiatry
Specialty Psychiatry
Date 2006 Jul 20
PMID 16848669
Citations 12
Authors
Craig A Erickson
Joanna E Chambers
Affiliations
Soon will be listed here.
Citing Articles

Aggression in autism spectrum disorder: presentation and treatment options.

Fitzpatrick S, Srivorakiat L, Wink L, Pedapati E, Erickson C Neuropsychiatr Dis Treat. 2016; 12:1525-38.

PMID: 27382295 PMC: 4922773. DOI: 10.2147/NDT.S84585.

Emerging pharmacologic treatment options for fragile X syndrome.

Schaefer T, Davenport M, Erickson C Appl Clin Genet. 2015; 8:75-93.

PMID: 25897255 PMC: 4396424. DOI: 10.2147/TACG.S35673.

Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes.

Wang H, Pati S, Pozzo-Miller L, Doering L Front Cell Neurosci. 2015; 9:55.

PMID: 25767435 PMC: 4341567. DOI: 10.3389/fncel.2015.00055.

The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review.

Rossignol D, Frye R Front Pediatr. 2014; 2:87.

PMID: 25202686 PMC: 4141213. DOI: 10.3389/fped.2014.00087.

Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.

Doyle C, McDougle C Dialogues Clin Neurosci. 2012; 14(3):263-79.

PMID: 23226952 PMC: 3513681.